PMID: 9426090Jan 13, 1998Paper

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

The European Respiratory Journal
T BuryP Rigo

Abstract

Despite advances in morphological imaging, some patients with lung cancer are found to have nonresectable disease at surgery or die of recurrence within yr of surgery. We performed a prospective study in 109 patients to compare the accuracy of whole-body positron emission tomography (PET) using fluorine-18 deoxyglucose (18FDG) and conventional imaging (CI) methods for the staging of non-small cell lung cancer (NSCLC). When CI or PET study suggested metastatic disease, confirmation was obtained by biopsy or follow-up information. As compared to CI, 18FDG-PET correctly changed the N stage in 22 patients (33%) and the M stage in 15 patients (14%). For the detection of distant metastases, PET study showed five false-positive sites and no false-negative cases. Currently, the accuracy of PET in the detection of M stage is 96%. Our study shows that visual interpretation of whole-body fluorine-18 deoxyglucose-positron emission tomography images can improve the diagnostic accuracy in the staging of non-small cell lung cancer. Further experience is needed to establish if metabolic imaging would be a cost-effective tool in the future management of lung cancer.

Citations

Nov 5, 2005·European Journal of Nuclear Medicine and Molecular Imaging·S M EschmannR Bares
Aug 10, 2006·European Journal of Nuclear Medicine and Molecular Imaging·S M EschmannR Bares
Nov 15, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Susanne Martina EschmannRoland Bares
Dec 31, 2003·Current Treatment Options in Oncology·Bruce R Line, Charles S White
Dec 1, 2009·The Indian Journal of Surgery·Ayesha S Bryant, Robert J Cerfolio
Mar 12, 2004·The Journal of Surgical Research·Alan D L Sihoe, Anthony P C Yim
Jul 12, 2003·Seminars in Roentgenology·Beatrice Trotman-Dickenson, Bernhard Baumert
May 12, 1998·Journal of Hepatology·Y DeugnierO Loréal
Mar 4, 2000·Advanced Drug Delivery Reviews·A BhatnagarA Alavi
May 17, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·E M MaromE F Patz
Nov 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·U Haberkorn
Dec 13, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·U Haberkorn, S O Schoenberg
Nov 13, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Johan F Vansteenkiste
Dec 25, 2002·European Journal of Radiology·Sigrid StroobantsJohan Vansteenkiste
Nov 27, 2002·Surgical Oncology·Sean C Grondin, Michael J Liptay
Oct 1, 2003·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·H W.D. YeungS M. Larson
Jun 13, 2002·Australasian Radiology·A M Scott
Aug 2, 2001·Internal Medicine Journal·A M Scott
Nov 29, 2007·Journal of the National Cancer Institute·Yee C UngUNKNOWN Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
Jan 14, 2000·Clinical Nuclear Medicine·S K LauM N Coel
May 24, 2000·Nuclear Medicine Communications·M J O'Doherty
Jul 17, 1999·Current Opinion in Pulmonary Medicine·P S SarinasG M Segall
Feb 7, 2007·American Journal of Clinical Oncology·Victoria KutAthanassios Argiris
Jun 29, 2004·Current Opinion in Pulmonary Medicine·Johny A VerschakelenJan Bogaert
Jun 25, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Eun Young HeoYoung Whan Kim
Mar 18, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Lale KostakogluStanley J Goldsmith
Sep 9, 1999·Radiology·E M MaromE F Patz
Apr 24, 2004·Radiology·Gottfried J SchafflerReingard M Aigner
Jan 31, 2002·Annual Review of Medicine·Johannes Czernin, Michael E Phelps
Aug 30, 2005·International Journal of Radiation Oncology, Biology, Physics·Elisabeth Deniaud-AlexandreJean-Noël Talbot
May 9, 2003·Clinics in Geriatric Medicine·Jamie C Hey
Aug 6, 2000·Seminars in Nuclear Medicine·R Bar-ShalomM D Blaufox
Nov 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·D Ukena, D Hellwig
Oct 10, 2002·The Surgical Clinics of North America·Walter J Scott
Dec 13, 2005·Expert Review of Anticancer Therapy·Rakesh KumarAnil Chauhan
Mar 20, 2004·Seminars in Nuclear Medicine·Eric M Rohren, Val J Lowe
Nov 25, 2004·The Oncologist·Liesbet SchrevensJohan Vansteenkiste

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.